Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022

Beatriz Martín-Antonio

doi:10.3389/fimmu.2023.1257016

Editorial: Expert opinions and perspectives in adoptive cell therapy for cancer: 2022

Front Immunol. 2023 Jul 20:14:1257016. doi: 10.3389/fimmu.2023.1257016. eCollection 2023.

Author

Beatriz Martín-Antonio¹

Affiliation

¹ Department of Experimental Hematology, Instituto de Investigación Sanitaria-Fundación Jiménez Diaz (IIS-FJD), University Autonomous of Madrid (UAM), Madrid, Spain.

No abstract available

Keywords: CAR affinity; CAR-T; cytokine; gamma-delta T cells; tumor microenvironment.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Expert Testimony
Humans
Immunotherapy, Adoptive
Neoplasms* / therapy
Receptors, Chimeric Antigen* / genetics

Substances

Receptors, Chimeric Antigen

Grants and funding

BM-A is funded by “Fondo Europeo de Desarrollo Regional (FEDER)” with two grants from the Institute of Health Carlos III, grant numbers PI20/00991 and CP21/00111.